Andras Janosi Selected Research

Peptides (Polypeptides)

4/2013

Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andras Janosi Research Topics

Disease

1	Acute Coronary Syndrome 01/2020
1	ST Elevation Myocardial Infarction 04/2013
1	Reperfusion Injury 04/2013
1	Infarction (Infarctions) 04/2013
1	Myocardial Infarction 04/2013
1	Heart Failure 04/2007
1	Overweight 04/2007

Drug/Important Bio-Agent (IBA)

1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	EnzymesIBA 04/2013
1	GadoliniumIBA 04/2013
1	Peptides (Polypeptides)IBA 04/2013
1	MB Form Creatine KinaseIBA 04/2013
1	arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA 04/2013
1	Valsartan (Vals)FDA Link 04/2007
1	C-Reactive ProteinIBA 04/2007
1	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2007

Therapy/Procedure

1	Percutaneous Coronary Intervention 04/2013
1	Therapeutics 04/2013